<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Only recently are we beginning to understand the complex interplay of factors involved in <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> provides a starting point to explain the many factors that lead to the more severe <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> characteristic of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> syndrome comprises <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and compensatory <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> as well as <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, macrovascular disease, and increased plasminogen activator inhibitor-1 activity </plain></SENT>
<SENT sid="3" pm="."><plain>The development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may be viewed as the inability of the pancreas to continue to overcome <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, even with excessive insulin production </plain></SENT>
</text></document>